Moderna - Stock Price History | MRNA
Historical daily share price chart and data for Moderna since 2023 adjusted for splits. The latest closing stock price for Moderna as of January 31, 2023 is 176.06.
- The all-time high Moderna stock closing price was 484.47 on August 09, 2021.
- The Moderna 52-week high stock price is 217.25, which is 23.4% above the current share price.
- The Moderna 52-week low stock price is 115.03, which is 34.7% below the current share price.
- The average Moderna stock price for the last 52 weeks is 156.15.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Moderna Historical Annual Stock Price Data |
Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
2022 |
156.6229 |
235.0500 |
235.0500 |
117.1300 |
179.6200 |
-29.28% |
2021 |
247.6753 |
111.7300 |
484.4700 |
109.1800 |
253.9800 |
143.11% |
2020 |
62.5042 |
19.2300 |
169.8600 |
17.7800 |
104.4700 |
434.10% |
2019 |
18.1192 |
15.3300 |
28.3400 |
12.2600 |
19.5600 |
28.09% |
2018 |
16.4338 |
18.6000 |
18.8000 |
13.5200 |
15.2700 |
0.00% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Biomedical and Genetics |
$67.639B |
$18.471B |
Moderna, Inc. is a clinical-stage pharmaceutical company, primarily focused on discovering and developing messenger RNA (mRNA) based therapies. The company's mRNA based COVID-19 vaccine, Spikevax (mRNA-1273), is approved for use in adults in the United States. The vaccine is also authorized for emergency use in several countries as COVID-19 vaccine. The company has also developed booster doses of its COVID-19 vaccine and is developing variant-specific booster candidates.
|